Reckitt Benckiser Group (RB) Receives Overweight Rating from JPMorgan Chase & Co.

Reckitt Benckiser Group (LON:RB)‘s stock had its “overweight” rating restated by stock analysts at JPMorgan Chase & Co. in a note issued to investors on Thursday. They presently have a GBX 7,500 ($101.71) target price on the stock. JPMorgan Chase & Co.’s price target suggests a potential upside of 8.49% from the stock’s previous close.

RB has been the topic of a number of other reports. Barclays reiterated an “equal weight” rating and issued a GBX 6,600 ($89.50) price target (down from GBX 7,100 ($96.28)) on shares of Reckitt Benckiser Group in a research report on Monday, November 27th. Royal Bank of Canada set a GBX 5,600 ($75.94) price target on shares of Reckitt Benckiser Group and gave the company a “sell” rating in a research report on Friday, October 20th. Liberum Capital cut their price target on shares of Reckitt Benckiser Group from GBX 8,700 ($117.98) to GBX 8,000 ($108.49) and set a “buy” rating on the stock in a research report on Wednesday, October 25th. Kepler Capital Markets cut their price target on shares of Reckitt Benckiser Group from GBX 7,800 ($105.78) to GBX 7,300 ($99.00) and set a “hold” rating on the stock in a research report on Monday, October 9th. Finally, Deutsche Bank reiterated a “buy” rating and issued a GBX 8,500 ($115.27) price target on shares of Reckitt Benckiser Group in a research report on Thursday, October 12th. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and nine have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of GBX 7,614.55 ($103.26).

Reckitt Benckiser Group (LON RB) traded up GBX 120 ($1.63) during trading on Thursday, reaching GBX 6,913 ($93.75). 1,993,768 shares of the company’s stock were exchanged, compared to its average volume of 1,090,000. Reckitt Benckiser Group has a 52 week low of GBX 6,299 ($85.42) and a 52 week high of GBX 8,110.43 ($109.99). The firm has a market cap of $48,650.00 and a P/E ratio of 2,312.04.

In other Reckitt Benckiser Group news, insider Adrian Nevil Hennah bought 2,285 shares of the firm’s stock in a transaction on Wednesday, November 8th. The shares were purchased at an average price of GBX 6,567 ($89.06) per share, for a total transaction of £150,055.95 ($203,493.29). Also, insider Christopher Sinclair bought 2,800 shares of the firm’s stock in a transaction on Wednesday, November 1st. The stock was acquired at an average price of GBX 6,597 ($89.46) per share, for a total transaction of £184,716 ($250,496.34).

TRADEMARK VIOLATION WARNING: This report was originally posted by American Banking News and is the sole property of of American Banking News. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://www.americanbankingnews.com/2018/01/21/reckitt-benckiser-group-rb-receives-overweight-rating-from-jpmorgan-chase-co.html.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply